Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine
Jul 22, 2026, 20:04

Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine

Maria Cherska, The Head of Cardiology Department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn about a recent article by Tania Guillemette et al., published in Lipids in Health and Desease, adding:

“We’ve spent decades asking why women develop cardiovascular disease later than men.

Perhaps the better question is:

Why have we spent so little time studying what protects women in the first place?

For years, biomedical research has treated male physiology as the default. Yet lipid metabolism, inflammation, insulin resistance, and even LDL receptor regulation are profoundly influenced by sex hormones, particularly estrogen.

Understanding these mechanisms isn’t just about women’s health.

It’s about improving precision cardiometabolic medicine for everyone.

The future of prevention won’t rely on ‘one-size-fits-all’ risk models—it will account for biology, sex, hormonal status, and metabolic phenotype.

An excellent review that reminds us that sex is not merely a demographic variable—it’s a biological determinant of cardiometabolic disease.”

Title: Exploring sex bias in cardiometabolic diseases

Authors: Tania Guillemette, David Rhainds, Océane Robert, Catherine Mounier

Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine

 

Find more posts featuring Maria Cherska on Hemostasis Today.